Glycosylated specificity exchangers
US7534435B2 · kind B2 · utility
2Cited by
62References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2006 |
| Grant date | May 19, 2009 |
| Priority date | — |
| Expiry date | Sep 27, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to ligand/receptor and antigen/antibody specificity exchangers comprising a saccharide or glycoconjugate. Methods of making these specificity exchangers and methods of using said specificity exchangers to treat or prevent human disease are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.